Gal-1 deficiency in CD4+ T cells was shown to impair T cell migration to the tumor site, whereas tumor-derived Gal-1 was shown to promote metastases accompanied by reduced tumor infiltration by immune cells [59]. Here, LGALS1 is linked to neoplasm.